
Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins Acquisition offers customers worldwide a single point of access for cGMP cell culture solutions for biopharmaceuticals, and cell and gene therapies
News Release
March 22, 2022
Print
TOKYO, March 23, 2022 - FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life science research, bioproduction, and cell therapy manufacturing, will acquire Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. Terms of the deal were not disclosed.
Shenandoah Biotechnology is a privately held company located in Warminster, Pennsylvania, that manufactures recombinant proteins including cytokines and growth factors. Shenandoah Biotechnology recently launched their CTG Grade line of cytokines and growth factors that are manufactured according to cGMP guidelines in the Company's new state-of-the-art, ISO 9001:2015 certified facility.
The use of cGMP manufactured products smooths the transition of biological therapies from preclinical to clinical phases.
At Fujifilm, our goal has always been to bring new value to society through the creation of innovative technologies, products and services, said Teiichi Goto, president and chief executive officer, representative director of FUJIFILM Corporation. The acquisition of Shenandoah Biotechnology marks an important milestone for us to establish a leading position as a partner for pharmaceutical customers in the rapidly-growing market of advanced therapy. Fujifilm will, by maximizing our group synergy, continue to expand Life Sciences Business while contributing to the creation of new therapies that fulfill unmet medical needs.
FUJIFILM Irvine Scientific is committed to helping customers bring advanced therapies to market faster, and to use innovation to make therapies more accessible, said Yutaka Yamaguchi, chairman and chief executive officer, FUJIFILM Irvine Scientific. Shenandoah Biotechnology's portfolio of recombinant proteins complement our advanced cell culture solutions and expertise in bioprocessing, providing our collective customers a single point of access for their life science research, discovery, and cell and gene therapy needs. This acquisition will be an important step toward achieving sales target of 100 billion yen (about 850 million USD*1) in Fujifilm's Life Sciences Business by FY2025.
*1 At an exchange rate of 1 USD = 118 JPY on March 23, 2022.
Yamaguchi added, The team at Shenandoah Biotechnology has years of proven experience in supplying the life science industry with high quality recombinant proteins at scale. We are excited to welcome all members of their talented team to the Fujifilm family, and look forward to what we can achieve together.
At Shenandoah Biotechnology, our vision is to provide a superior and affordable source of recombinant proteins to the drug discovery, life science research, and cell and gene therapy markets. We are pleased to join FUJIFILM Irvine Scientific given their experience with manufacturing ancillary materials for cell and gene therapy and commitment to providing high quality products and service to customers, said Pamela De Lacy, president, Shenandoah Biotechnology. We look forward to working with the team at FUJIFILM Irvine Scientific and continuing to build on our success.
The deal is expected to close later this month.
About Recombinant Proteins:
Recombinant proteins are used in a variety of life science applications. They are made by cloning engineered DNA into expression systems ( cell factories ) for the purpose of large-scale production of proteins of interest. Specific types of recombinant proteins such as growth factors and cytokines are essential for cell therapy, gene therapy and regenerative medicine in the areas of research, development and manufacturing. Growth factors and cytokines are important drivers of many cellular processes such as cell proliferation, growth, differentiation and cell signaling.
FUJIFILM Irvine Scientific www.irvinesci.com/
FUJIFILM Irvine Scientific, Inc., is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivaled service and quality to scientists working in biopharmaceuticals, cell therapy, and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. FUJIFILM Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA, and Tokyo, Japan. The company's consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 50 years, FUJIFILM Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services. FUJIFILM Irvine Scientific, Inc. is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation.
FUJIFILM Holdings Corporation holdings.fujifilm.com/en
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions, and imaging. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging te
More from Fujifilm
01/07/2022
Fujifilm announces price increase for select Fujifilm-manufactured LTO Ultrium d...
16/06/2022
Fujifilm UK appoints Martin Fairweather as National Digital Business Manager
June 16, 2022
Print
Martin Fairweather, National Digital Business Manager, Fu...
15/06/2022
Fujifilm Europe introduces the new instax mini Link 2 Smartphone Printer New, interactive product features are designed to inspire creativity
June 15, 2022
...
08/06/2022
Fujifilm Acquires European Inkjet System Integrator UNIGRAPHICA to Expand Inkjet...
07/06/2022
Fujifilm forms strategic partnership with Impresa to support wide format sales i...
07/06/2022
Langford Vets - University of Bristol Install Fujifilm's SYNAPSE PACS System
News Release
June 7, 2022
Print
A modern and reliable PACS system is cru...
31/05/2022
Fujifilm announces first foray into the high-end wide format hybrid market with ...
31/05/2022
Fujifilm announces the addition of the Acuity Prime L to its Acuity Prime series...
27/05/2022
Fujifilm forms strategic partnership with Blu Sign to boost wide format sales in...
26/05/2022
Fujifilm partners with Logatek to boost wide format sales in the Italian market Logatek is set to increase the market presence of the Acuity Prime in Italy
...
26/05/2022
Fujifilm announces agreement with Color-Logic Inc to sell the world's leadin...
23/05/2022
Fujifilm announces partnership with Papyrus Viscom to sell and distribute Acuity...
19/05/2022
RGI partners with Fujifilm for first major digital investment
May 19, 2022
Print
The company becomes the first commercial offset print business in France ...
17/05/2022
Fujifilm launches Activ Hybrid LED UV retrofit system
May 17, 2022
Print
Fujifilm today announces the launch of the Activ Hybrid LED UV curing system, whi...
16/05/2022
Acuity Prime and Acuity Ultra R2 each scoop a third design award
May 16, 2022
Print
Acuity Prime
Acuity Ultra R2
Ahead of their appearance at FESPA, und...
13/05/2022
Fujifilm appoints Colm Garvey as European Dealer Manager in push to find new mar...
12/05/2022
Fujifilm reflects on a year of unprecedented digital print success
May 12, 2022
Print
Fujifilm's 2021-22 fiscal year was its best ever for Jet Press s...
10/05/2022
Fujifilm announces a price increase for its aluminium offset printing plates
May 10, 2022
Print
Fujifilm announces today that it will be implementing a do...
10/05/2022
Fujifilm reveals FUJIFILM PROJECTOR Z6000
May 10, 2022
Print
- Z Series of ultra-short-throw projectors equipped with the world's first folded two-ax...
28/04/2022
Fujifilm launches mobile training hub to tackle endoscopy challenges as clinicia...
13/04/2022
Floricolor marks Revoria investment with successful open house event Fujifilm's new Revoria Press PC1120 and the Jet Press 750S took centre stage at Flori...
11/04/2022
FUJIFILM presents heavy-duty lens series at UKIVA conference 2022 FUJIFILM attends UKIVA Machine Vision Conference 2022 with exhibition booth and technical ...
11/04/2022
Creation Reprographics signs four-year-deal for Fujifilm's Flenex-FW water-w...
05/04/2022
Fujifilm forms strategic partnership with MCA Digital to boost digital print pro...
04/04/2022
Fujifilm forms strategic partnership with Nautasign to boost Acuity Prime and Ac...
01/04/2022
Mirrorless digital camera and ultrasound diagnostic imaging devices win the Bes...
01/04/2022
Tech:art reaps productivity benefits with Fujifilm's Acuity Prime 30 The Italian printers September 2021 investment in Fujifilms Acuity flatbed has result...
31/03/2022
Fujifilm announces Blueprint Live' concept at Fespa 2022 Fujifilm plans to make a splash at its first big exhibition appearance in two years, and its big...
29/03/2022
Fujifilm, Tokyo Gas and Minamiashigara City sign a comprehensive partnership ag...
28/03/2022
Fujifilm Invests $28 Million to Add a New Facility for Inkjet Pigment Dispersion...
22/03/2022
Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinan...
22/03/2022
Fujifilm's Flenex plates add the finishing touches to stunning book jacket d...
14/03/2022
Fujifilm's photographic Films become membranes to purify water
March 14, 2022
Print
This ion exchange solution is able to give new uses to already use...
03/03/2022
FUJIFILM to highlight the latest advances in radiology at ECR 2022 Overture
March 3, 2022
Print
The content on this page is intended to healthcare profess...
01/03/2022
Fujifilm appoints Manuel Schrutt as Head of Packaging for EMEA
March 1, 2022
Print
Schrutt brings to Fujifilm extensive packaging experience following man...
15/02/2022
Fujifilm brings a smile to young patients paediatric experiences with its Little...
10/02/2022
FUJIFILM VisualSonics and PIUR IMAGING Partner to Enable Ultra-High Frequency, 3...
09/02/2022
Fujifilm launches life sciences strategic investment fund focused on emerging co...
26/01/2022
Fujifilm appoints Mark Lawn as Head of POD Solutions Europe
January 26, 2022
Print
Mark Lawn, Head of POD Solutions Europe
Lawn's extensive experienc...
15/01/2022
King's College Hospital Choose Fujifilm CR
January 15, 2022
Print
The content on this page is intended to healthcare professionals and equivalents.
W...
12/01/2022
Fujifilms magazine Women4Women: the Green issue about sustainability Fujifilm tells the stories of women dealing with the sustainable revolution in their dail...
06/01/2022
FUJIFILM Holdings announces new climate action targets
January 6, 2022
Print
- Fully operating on carbon-free energy by FY2040
- Addressing climate chang...
20/12/2021
Fujifilm printlife@home exhibition: Tens of thousands of photos from members of ...
17/12/2021
High-impact, large format portraits set the scene as Fujifilm's Acuity Prime...
10/12/2021
Fujifilm partners with RA Smart to supply Acuity Prime to UK customers
December 10, 2021
Print
RA Smart Facilities
Fujifilm today announced that it has p...
10/12/2021
New Mobile for Nuffield Health Cambridge Hospital
December 10, 2021
Print
The content on this page is intended to healthcare professionals and equivalents...
08/12/2021
Fujifilm Kicks Off Operations at its New, State-of-the-Art Cell Culture Media Ma...
02/12/2021
Fujifilm wins top award for its service operation Fujifilm's UK Graphics Service team wins big at the European Field Service Awards
December 2, 2021
Pr...
01/12/2021
Fujifilm announces additional surcharge for its aluminium offset printing plates
December 1, 2021
Print
Fujifilm announces today that it will be adding an...